For the investigational use of Adipose Derived
Stem Cells (ADSC's) for clinical research and deployment.
Cytotherapy. 2010 Apr; 12(2) : 226-37. Gene therapy in hemiparkinsonian rhesus monkeys: long-term survival and behavioral recovery by transplantation of autologous human tyrosine hydroxylase-expressing neural stem cells. Xu Q, Jiang X, Ke Y, Zhang S, Xu R, Zeng Y. Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China 510282. Abstract BACKGROUND AIMS: Neural stem…
Rejuvenation Res. 2010 Apr-Jun; 13(2-3) : 188-94. Cellular repair in the parkinsonian nonhuman primate brain. Redmond DE Jr, Weiss S, Elsworth JD, Roth RH, Wakeman DR, Bjugstad KB, Collier TJ, Blanchard BC, Teng YD, Synder EY, Sladek JR Jr. Department of Psychiatry and Neurosurgery, Yale University School of Medicine, New Haven, Connecticut 06511, USA. eugene.redmond@yale.edu…
J Vasc Interv Radiol. 2010 Apr; 21(4) : 443-51. Intraarterial autologous implantation of adult stem cells for patients with Parkinson disease. Brazzini A, Cantella R, De la Cruz A, Yupanqui J, León C, Jorquiera T, Brazzini M, Ortega M, Saenz LN. Brazzini Institute of Radiology, Lima 27, Perú. research@brazzini.com Erratum in: Vasc Interv Radiol. 2010…
Adv Exp Med Biol. 2010; 671 : 117-30. Gene- and cell-based approaches for neurodegenerative disease. Urbaniak Hunter K, Yarbrough C, Ciacci J. Department of Radiation Oncology, Univesity of Michigan, Ann Arbor, Michigan, USA. kurbania@med.umich.edu Abstract Neurodegenerative diseases comprise an important group ofchronic diseases that increase in incidence with rising age. In particular, the two most…
Neuropharmacology. 2010 May; 58(6) : 855-64. Epub 2010 Feb 8. Recent advancements in stem cell and gene therapies for neurological disorders and intractable epilepsy. Naegele JR, Maisano X, Yang J, Royston S, Ribeiro E. Department of Biology and Program in Neuroscience and Behavior, Hall Atwater Laboratory, 52 Lawn Avenue, Wesleyan University, Middletown, CT 06459, USA.…
Stem Cells Dev. 2010 Mar; 19(3) : 311-20. Stem cell therapy for Parkinson’s disease: a road map for a successful future. Vidaltamayo R, Bargas J, Covarrubias L, Hernández A, Galarraga E, Gutiérrez-Ospina G, Drucker-Colin R. Depto de Neurociencias and Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, México. Abstract Cell transplant therapy for Parkinson’s…
Regen Med. 2010 Mar; 5(2) : 267-78. Stem cell-derived dopamine neurons for brain repair in Parkinson’s disease. Fricker-Gates RA, Gates MA. Keele University, Keele, Staffordshire, UK. r.a.fricker-gates@hfac.keele.ac.uk Abstract One of the prospects for a curative treatment for Parkinson’s disease is to replace the lost dopaminergic neurons. Preclinical and clinical trials have demonstrated that dissected fetal…
Transl Res. 2010 Feb; 155(2) : 62-70. Epub 2009 Aug 6. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson’s disease. Venkataramana NK, Kumar SK, Balaraju S, Radhakrishnan RC, Bansal A, Dixit A, Rao DK, Das M, Jan M, Gupta PK, Totey SM. Advanced Neuroscience Institute, BGS-Global Hospital, Bangalore, India. drnkvr@gmail.com Comment…
Neurosci Bull. 2010 Feb; 26(1) : 66-76. Treatment strategies for Parkinson’s disease. Yuan H, Zhang ZW, Liang LW, Shen Q, Wang XD, Ren SM, Ma HJ, Jiao SJ, Liu P. Department of Integrated Traditional Chinese and Western Medicine, the General Hospital of Chinese People’s Armed Police Forces , Beijing 100039, China. blsphd2005@126.com Abstract Parkinson’s disease…
J Clin Invest. 2010 Jan 4; 120(1) : 51-9. doi: 10.1172/JCI40553. Progress toward the clinical application of patient-specific pluripotent stem cells. Kiskinis E, Eggan K. The Stowers Medical Institute, Harvard Stem Cell Institute, Department of Stem Cell and Regenerative Biology, Harvard University, 7 Divinity Avenue, Cambridge, MA 02138, USA. ekiskinis@mcb.harvard.edu Abstract Induced pluripotent stem (iPS)…
